The purpose of Core E is to provide high quality results for total and allergen-specific IgE to Projects 2 and 4. The value of centralizing this testing is to reduce variation in the results and to gain purchasing efficiency by combining ordering for all reagents to a single laboratory. The Pediatric Allergy-Immunology Laboratory at Georgia Health Sciences University is CLlA-certified for patient care assays and participates in the quality , assurance program of the College of American Pathologists (CAP) for IgE testing. This laboratory has performed all of the IgE tests for the WHEALS study to date. The coefficients of variation for repeat assays are consistently in the range of 6% or less. Data from all assays is transmitted directly electronically from the analytic instruments to the study coordinators in Detroit for entry into the study database. This eliminates the risks of data corruption from transcription and transmission of data. Dr. Dennis Ownby, who will oversee the performance of the IgE assays, is highly knowledgeable in the area of IgE testing and he will assure the quality of the results reported for analysis in the proposed studies. A system of careful sample tracking and identification based on bar coding all samples has been developed which minimizes the risks of sample loss during shipping or of not matching samples and the results from testing the sample. As in the past, 1% of all samples will be re-assayed weeks to months later to assure quality control and to assure that all samples are correctly identified.

Public Health Relevance

By delegating these technical tasks to this Core, participating investigators do not need to allocate time and effort to these assays. A centralized Core will increase efficiency and reliability and contribute to decreasing overall costs by eliminating duplication of effort, instruments and by allowing the purchase of expensive reagents in bulk quantities.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Henry Ford Health System
United States
Zip Code
Durack, Juliana; Boushey, Homer A; Huang, Yvonne J (2018) Incorporating the airway microbiome into asthma phenotyping: Moving toward personalized medicine for noneosinophilic asthma. J Allergy Clin Immunol 141:82-83
Wegienka, Ganesa; Sitarik, Alexandra; Bassirpour, Gillian et al. (2018) The associations between eczema and food and inhalant allergen-specific IgE vary between black and white children. J Allergy Clin Immunol Pract 6:292-294.e2
Sitarik, Alexandra Rene; Kasmikha, Nena Sabri; Kim, Haejin et al. (2018) Breast-feeding and delivery mode modify the association between maternal atopy and childhood allergic outcomes. J Allergy Clin Immunol 142:2002-2004.e2
Cassidy-Bushrow, A E; Burmeister, C; Havstad, S et al. (2018) Prenatal antimicrobial use and early-childhood body mass index. Int J Obes (Lond) 42:1-7
Sitarik, A R; Havstad, S; Levin, A M et al. (2018) Dog introduction alters the home dust microbiota. Indoor Air 28:539-547
Sitarik, Alexandra R; Bobbitt, Kevin R; Havstad, Suzanne L et al. (2017) Breast Milk Transforming Growth Factor ? Is Associated With Neonatal Gut Microbial Composition. J Pediatr Gastroenterol Nutr 65:e60-e67
Johnson, Christine C; Ownby, Dennis R (2017) The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Transl Res 179:60-70
Havstad, Suzanne; Sitarik, Alexandra R; Johnson, Christine Cole et al. (2017) Allergic sensitization in American children of Middle Eastern ethnicity at age 2. Ann Allergy Asthma Immunol 119:464-466
Fonseca, W; Lucey, K; Jang, S et al. (2017) Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation. Mucosal Immunol 10:1569-1580
Cassidy-Bushrow, Andrea E; Sitarik, Alexandra R; Havstad, Suzanne et al. (2017) Burden of higher lead exposure in African-Americans starts in utero and persists into childhood. Environ Int 108:221-227

Showing the most recent 10 out of 49 publications